BDBM72162 2-(3-phthalimidopropanoylamino)-N-(tetrahydrofurfuryl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide::2-[3-(1,3-dioxoisoindol-2-yl)propanoylamino]-N-(oxolan-2-ylmethyl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide::2-[3-[1,3-bis(oxidanylidene)isoindol-2-yl]propanoylamino]-N-(oxolan-2-ylmethyl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide::2-[[3-(1,3-dioxo-2-isoindolyl)-1-oxopropyl]amino]-N-(2-oxolanylmethyl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide::2-{[3-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)propanoyl]amino}-N-(tetrahydro-2-furanylmethyl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide::MLS000578340::SMR000198240::cid_2938214
SMILES COC(=O)[C@@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](O)[C@H](C)C(C)C
InChI Key InChIKey=HQZFEAHZYTVXRL-UHFFFAOYSA-N
Data 1 EC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 2 hits for monomerid = 72162
Memorial Sloan-Kettering Cancer Center; Memorial Hospital for Cancer and Allied Diseases; Sloan-Kettering Institute for Cancer Research
US Patent
Memorial Sloan-Kettering Cancer Center; Memorial Hospital for Cancer and Allied Diseases; Sloan-Kettering Institute for Cancer Research
US Patent
